首页> 美国卫生研究院文献>Drugs in Context >Thyrotoxicosis after massive triiodothyronine (LT3) overdose: a coast-to-coast case series and review
【2h】

Thyrotoxicosis after massive triiodothyronine (LT3) overdose: a coast-to-coast case series and review

机译:大量三碘甲状腺素(LT3)过量后的甲状腺毒症:从海岸到海岸的病例系列和回顾

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Excessive exogenous thyroid hormone ingestion may lead to severe thyrotoxicosis and cause potential harm. We have reviewed the literature and suggested that thyroid hormone supplementation should not be used to alleviate nonspecific complaints in patients with normal endogenous thyroid function. Failure to do so may cause serious harm, as demonstrated in one of the cases described here. In addition, treatment based on symptom relief only without biochemical measure may lead to overmedication – as reported from academic hospitals both in Canada and the United States. Given the risk of severe thyrotoxicosis from potential compounding errors, pharmacies providing a compounding service should be subject to more rigorous monitoring by the food and drug administration. Clinicians should also use local biochemical markers when titrating thyroid hormone supplements even though the normal thyroid function reference range has its limitation, failure to do so may result in iatrogenic thyrotoxicosis.
机译:过量摄入外源性甲状腺激素可能导致严重的甲状腺毒症,并可能造成伤害。我们已经查阅了文献,并建议内源性甲状腺功能正常的患者不应使用补充甲状腺激素来缓解非特异性症状。否则,可能会造成严重伤害,如此处所述情况之一所示。此外,仅在没有生化措施的情况下基于症状缓解的治疗可能会导致用药过量-加拿大和美国的学术医院都报道过。考虑到潜在的复合错误导致严重的甲状腺毒症的风险,提供复合服务的药房应接受食品和药物管理局的更严格监控。即使正常甲状腺功能参考范围有其限制,临床医生在滴定甲状腺激素补充剂时也应使用局部生化标志物,否则可能会导致医源性甲状腺毒症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号